Table 4.
Disease | Gene | Exon | Phase | Author, Year |
---|---|---|---|---|
LGMD2B | DYSF | 32 | P | Barthelemy et al. 2015 (26) |
Laminopathy | LMNA | 5 | P | Scharner et al. 2015 (27) |
Joubert syndrome | CEP290 | 41 | P | Molinari et al. 2019 (31) |
Alport syndrome | COL4A5 | 21 | P | Yamamura et al. 2020 (29) |
Dystrophic epidermolysis bullosa | COL7A1 | 73 | P | Bornert et al. 2020 (30) |
CADASIL | NOTCH3 | 9 | P | Gravesteijn et al. 2020 (32) |
Mucolipidosis II | GNPTAB | 19 | P | Matos et al. 2020 (33) |
Myotonic dystrophy type1 | DMPK | 15 | P | Stepniak et al. 2020 (34) |
LGMD2B: limb girdle muscular dystrophy 2B; CADASIL: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; P: preclinical study